🔎 Trials Near Me

Pradžia › Lėtinė inkstų liga › Ilinoisas

Lėtinė inkstų liga klinikiniai tyrimai Ilinoisas

17 tyrimai dėl Lėtinė inkstų liga ieško dalyvių vietose Ilinoisas.

Miestai Ilinoisas

Oficialus tyrimo tekstas (anglų kalba)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Accellacare - DuPage, Lombard
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Champaign
  • Research Site, Maywood
  • Research Site, Rockford
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06742723

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

  • Comprehensive Transplant Center, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-25 · NCT05106387

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Oak Brook
  • Research Site, Rockford
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07624305

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07107945

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Research by Design, LLC - Internal Medicine, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07271186

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Champaign
  • Research Site, Chicago
  • Research Site, Chicago
  • ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07753993

Breakthrough - T1DM and Chronic Kidney Disease

  • The University of Chicago, Chicago
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07592000

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius nuo 12 iki 25 · Visoms lytims · Atnaujinta 2026-08-19 · NCT06430684

Study of BHV-1400 in IgA Nephropathy

  • Site-009, Hinsdale
Renkami dalyviai1 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07054684

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT01644903

Empagliflozin Treatment in Kidney Transplant Recipients

  • Edward Hines Jr. VA Hospital, Hines, IL, Hines
Renkami dalyviai4 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-04-21 · NCT06013865

Kidney Precision Medicine Project

  • University of Illinois Chicago, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-14 · NCT04334707

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviai1/2 fazė
Amžius nuo 40 iki 70 · Visoms lytims · Atnaujinta 2026-03-27 · NCT06878560

Transformative Research in Diabetic Nephropathy

  • Northwestern University, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-02-27 · NCT02986984

Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

  • University of Chicago Medical Center, Chicago
Renkami dalyviai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2025-11-14 · NCT06397456

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.